Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

65
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A...
65
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.4K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.4K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

430
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
430
Pharmacokinetic–Pharmacodynamic Relationship: Model Components01:14

Pharmacokinetic–Pharmacodynamic Relationship: Model Components

85
Pharmacokinetic-pharmacodynamic (PK–PD) modeling is essential in drug development and clinical pharmacology. It provides a quantitative framework to predict drug behavior and response over time. This approach integrates pharmacokinetics (PK), which describes the drug's absorption, distribution, metabolism, and excretion, with pharmacodynamics (PD), which characterizes the drug’s biological effects and mechanisms of action.The disposition kinetics of a drug determine its plasma...
85
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

326
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
326
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

122
Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
122

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mortality among workers at the Rocky Flats Plant, 1951-2017.

Journal of radiological protection : official journal of the Society for Radiological Protection·2026
Same author

Age- and sex-specific cancer risk predictions for some important radionuclides in a Swedish population-use of the updated ORNL computation method for chronic exposure.

Radiation protection dosimetry·2025
Same author

Approaches to harmonize mortality data sets in three diverse radiation worker cohorts.

Journal of radiological protection : official journal of the Society for Radiological Protection·2025
Same author

Distribution of plutonium and radium in the human heart.

Journal of radiological protection : official journal of the Society for Radiological Protection·2024
Same author

Third mortality follow-up of the Mallinckrodt uranium processing workers, 1942-2019.

International journal of radiation biology·2023
Same author

Plutonium Systemic Biokinetic Model for Rats.

Radiation research·2022

Related Experiment Video

Updated: Mar 11, 2026

Quantification of Metal Leaching in Immobilized Metal Affinity Chromatography
05:35

Quantification of Metal Leaching in Immobilized Metal Affinity Chromatography

Published on: January 17, 2020

8.1K

A Biokinetic Model for Systemic Nickel.

Dunstana R Melo1, Richard W Leggett

  • 1*Melohill Technology LLC, Rockville, MD 20850; †Oak Ridge National Laboratory, Oak Ridge, TN 37831-6153.

Health Physics
|December 2, 2016
PubMed
Summary
This summary is machine-generated.

The International Commission on Radiological Protection updated its nickel biokinetic model for radiation protection. The new model offers a more realistic human body nickel behavior description, reducing dose estimates for key nickel radioisotopes.

More Related Videos

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
11:04

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Published on: September 7, 2019

9.9K
Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
06:12

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Published on: March 3, 2023

1.3K

Related Experiment Videos

Last Updated: Mar 11, 2026

Quantification of Metal Leaching in Immobilized Metal Affinity Chromatography
05:35

Quantification of Metal Leaching in Immobilized Metal Affinity Chromatography

Published on: January 17, 2020

8.1K
Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
11:04

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Published on: September 7, 2019

9.9K
Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
06:12

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Published on: March 3, 2023

1.3K

Area of Science:

  • Radiological protection
  • Biokinetics
  • Human health

Background:

  • The International Commission on Radiological Protection (ICRP) develops biokinetic models for internally deposited radionuclides.
  • Existing models require updates based on new scientific data.
  • Nickel radioisotopes are relevant for radiation protection assessments.

Purpose of the Study:

  • To review existing data on nickel biokinetics in humans and animals.
  • To propose an updated biokinetic model for systemic nickel in adult humans.
  • To improve radiation dose estimations for nickel radioisotopes.

Main Methods:

  • Literature review of nickel biokinetic data.
  • Development of a new systemic nickel biokinetic model for adults.
  • Comparison of the proposed model with the current ICRP model.

Main Results:

  • The proposed model is based on a larger dataset than the current ICRP model.
  • The updated model provides a more realistic representation of nickel's behavior in the human body.
  • For Ni-63 and Ni-59, the proposed model yields lower dose estimates per unit activity compared to the current ICRP model.

Conclusions:

  • The updated nickel biokinetic model offers a more realistic basis for radiation protection.
  • The revised model leads to reduced dose estimates for important nickel radioisotopes.
  • This work contributes to the ICRP's ongoing refinement of radionuclide biokinetic models.